Company Description

Aptimmune Biologics has created a series of advanced enabling technologies which provide solutions to today's most challenging and economically important swine diseases. Using the Barricade^R platform technology, they have empowered stakeholders to address the Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and Swine Influenza A virus (IAV-S) vaccine markets in multiple geographies